Skip to Content

Notice

National Institute of Allergy and Infectious Diseases; Opportunity for a Cooperative Research and Development Agreement (CRADA) to Develop Eosinophil-Derived Neutralizing Agent (EDNA) to Treat Infections in Children and the Elderly Caused by Respiratory Syncytical Virus and Parainfluenza Virus

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.